Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Multicenter, Double-blind, Placebo-controlled Phase 2 Study to Evaluate Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT06058156 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06058156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06058156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Multicenter, Double-blind, Placebo-controlled Phase 2 Study to Evaluate Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Terminated
Start date
November 9, 2023
Completion date
November 20, 2025
Enrollment
70 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis